Costacou Tina, Ellis Demetrius, Fried Linda, Orchard Trevor J
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Am J Kidney Dis. 2007 Nov;50(5):721-32. doi: 10.1053/j.ajkd.2007.08.005.
The sensitivity of albuminuria in predicting loss of kidney function has been questioned. We determined the sequence of kidney disease stages (microalbuminuria, macroalbuminuria, low estimated glomerular filtration rate [eGFR], and end-stage renal disease [ESRD]) and characterized those without albuminuria before a low eGFR.
The Pittsburgh Epidemiology of Diabetes Complications Study is a prospective cohort investigation of childhood-onset type 1 diabetes.
SETTING & PARTICIPANTS: 480 study participants with eGFR greater than 60 mL/min/1.73 m(2) (mean age, 27 years; diabetes duration, 19 years at study entry) were prospectively followed up for 16 years.
OUTCOMES & MEASUREMENTS: Low eGFR was defined as creatinine clearance less than 60 mL/min/1.73 m(2) from timed urine collections; microalbuminuria, as albumin excretion rate between 20 to 200 microg/min (30 to 300 mg/24 h); macroalbuminuria, as albumin excretion rate greater than 200 microg/min (>300 mg/24 h); and ESRD, as dialysis or renal transplantation.
The 33 of 480 individuals (7%) who developed ESRD had prior albuminuria. 71 of 480 (15%) individuals developed low eGFR. 66 of 71 (93%) had prior/concurrent albuminuria, and 5 of 71 (7%) did not. Incident low eGFR values in the 5 patients were: (1) 54, (2) 58, (3) 59, (4) 59.7, and (5) 59.8 mL/min/1.73 m(2). 3 of 5 (60%; patients 1, 4, and 5) subsequently developed albuminuria. Final eGFRs in the 5 patients were: (1) 94, (2) 86, (3) 60, (4) 65, and (5) 54 mL/min/1.73 m(2), respectively.
GFR and insulin sensitivity were not measured, but estimated. Incident decreased eGFR in patients without preceding/concurrent albuminuria may be caused by misclassification or a temporary eGFR decrease.
Moderately decreased eGFR may occur rarely in patients with type 1 diabetes without preceding albuminuria.
蛋白尿在预测肾功能丧失方面的敏感性受到质疑。我们确定了肾脏疾病阶段的顺序(微量白蛋白尿、大量白蛋白尿、低估算肾小球滤过率[eGFR]和终末期肾病[ESRD]),并对eGFR降低之前无白蛋白尿的情况进行了特征描述。
匹兹堡糖尿病并发症流行病学研究是一项对儿童期发病的1型糖尿病进行的前瞻性队列研究。
480名eGFR大于60 mL/min/1.73 m²(平均年龄27岁;研究入组时糖尿病病程19年)的研究参与者进行了为期16年的前瞻性随访。
低eGFR定义为根据定时尿液收集计算的肌酐清除率小于60 mL/min/1.73 m²;微量白蛋白尿定义为白蛋白排泄率在20至200微克/分钟(30至300毫克/24小时)之间;大量白蛋白尿定义为白蛋白排泄率大于200微克/分钟(>300毫克/24小时);ESRD定义为透析或肾移植。
480名个体中有33名(7%)发展为ESRD,这些个体之前有蛋白尿。480名个体中有71名(15%)出现低eGFR。71名中有66名(93%)之前/同时有蛋白尿,71名中有5名(7%)没有。5名患者的新发低eGFR值分别为:(1)54,(2)58,(3)59,(4)59.7,(5)59.8 mL/min/1.73 m²。5名中有3名(60%;患者1、4和5)随后出现蛋白尿。5名患者的最终eGFR分别为:(1)94,(2)86,(3)60,(4)65,(5)54 mL/min/1.73 m²。
GFR和胰岛素敏感性未进行测量,而是估算的。无前驱/同时期蛋白尿的患者中出现的新发eGFR降低可能是由于分类错误或eGFR暂时降低所致。
在无先前蛋白尿的1型糖尿病患者中,中度降低的eGFR可能很少发生。